TECX
Tectonic Therapeutic, Inc.
$36.54
+1.32 (+3.75%)
At close · Jul 7
Market Cap
$669.48M
Shares
18,869,186
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$36.54
Open$35.31
Day$34.57–38.33
52W$14.39–39.53
Avg vol 30d180K
Short int2.2M · 11.4% float · 16.7d
Short vol47%
Last earningsMay 7, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+52%
above
Price vs 50-day avg
+23%
above
RSI (14)
65
neutral
MACD trend
Positive
52-week position
88%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+26%
trailing
6-month return
+86%
trailing
YTD return
+75%
this year
Relative strength
+79%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $30 › 200d $24 — 50d above 200d
Institutional flow
Distributing
3 of 112 funds reported for Jun 30 · net -45 sh shares · +1 new
Insider flow
Distributing
Net -$32.0K over 90 days · 100% sells
Short interest
Falling
11.41% of float · ▼ -8.1% MoM · 16.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
112 holders — near 2-yr high, broad support
Squeeze score
90
high risk · 0–100
Fundamentals
EPS growth
+41%
Y/Y
Free cash flow
$-60.3M
Balance sheet
$238.8M
net cash
Quant / Vol
risk profile
Volatility
82%
annualized · 1-yr
Max drawdown
−45%
past year
ATR
6.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 6, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+52%
Bullish
Price vs 50-day avg
+23%
Bullish
RSI (14)
65
Neutral
MACD trend
Positive
Bullish
52-week position
88%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $30 › 200d $24 — 50d above 200d
Institutional flow
Distributing
3 of 112 funds reported for Jun 30 · net -45 sh shares · +1 new
Insider flow
Distributing
Net -$32.0K over 90 days · 100% sells
Short interest
Falling
11.41% of float · ▼ -8.1% MoM · 16.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
112 holders — near 2-yr high, broad support
Price context
position in its 52-week range
52-wk low $14
Now $37 · 88%
52-wk high $40
vs 200-day avg +52%
vs 50-day avg +23%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TECX
this stock
Tectonic Therapeutic, Inc.
|
$669.48M | +75.2% | — | — | 11.4% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TECX | +10.4% | +26.0% | +86.4% | +6.3% | +75.2% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +9.5% | +24.6% | +78.9% | +6.2% | +65.5% |